Gilead Sciences Inc. (GIS.DE)
88.65
0.46 (0.52%)
At close: Jan 14, 2025, 5:20 PM
undefined% (undefined)
| Bid | n/a |
| Market Cap | 110.48B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0.09 |
| PE Ratio (ttm) | 985 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 962 |
| Avg. Volume (20D) | 1,790 |
| Open | 87.55 |
| Previous Close | 88.19 |
| Day's Range | 87.40 - 88.73 |
| 52-Week Range | 57.29 - 92.80 |
| Beta | undefined |
About GIS.DE
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, V...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Jan 3, 2000
Employees 18,000
Stock Exchange XETRA
Ticker Symbol GIS.DE
Website https://www.gilead.com